Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$17,773,074
-$1,708,794 QoQ
Shares Held
69,981
-12.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#800
of 4,687 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HARBOUR INVESTMENTS, INC. holds $128,781,101 across 17 Drug Manufacturers - General names. JNJ ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
221,662 | $55,779,025 | |
| 2 | LLY |
ELI LILLY & Co
|
27,683 | $33,203,823 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
69,981 | $17,773,074 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,366 | $5,187,031 | |
| 5 | PFE |
Pfizer Inc
|
141,011 | $3,395,544 | |
| 6 | AMGN |
Amgen Inc
|
8,295 | $3,003,785 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
50,112 | $2,887,453 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
22,237 | $2,809,422 |
All Filings in JNJ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,773,074 | 69,981 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $19,481,868 | 79,700 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,636,384 | 56,228 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $5,379,405 | 29,012 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,735,762 | 37,550 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $6,310,212 | 38,050 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $5,180,722 | 35,823 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $5,858,469 | 36,150 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $4,103,149 | 28,073 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $4,285,683 | 27,092 | Shares | Sole | 2024-07-22 | |
| 2023-12-31 | $4,084,174 | 26,057 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $3,898,734 | 25,032 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $4,506,116 | 27,224 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,410,930 | 22,006 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,862,098 | 21,863 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $3,265,566 | 19,990 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,548,424 | 19,990 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $3,309,349 | 19,345 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $9,330,339 | 57,773 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,512,059 | 63,810 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,935,943 | 60,456 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||